XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
   Antidepressants
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
  Suicide
  CFS
  Psychoses
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Antidepressants Channel
subscribe to Antidepressants newsletter

Latest Research : Psychiatry : Depression : Antidepressants

   DISCUSS   |   EMAIL   |   PRINT
Research shows St. John's Wart as effective as Paroxetine
Feb 11, 2005, 19:43, Reviewed by: Dr.



 
A specially manufactured extract from the herb St John's Wort is at least as effective in treating depression as a commonly prescribed anti-depressant, according to new research published on bmj.com today.

St John's Wort* and the anti-depressant drug Paroxetine** were used in a trial to treat patients with moderate or severe depression. The researchers asked 301 participants of both sexes from German mental health centres to take part in the trial. The two drugs were taken by the patients aged 18-70 over a six week period during 2000 -2003.

At the end of the trial half (61 out of 122) of those who took St John's Wort found their symptoms in decline, whilst only a third (43 out of 122) of those taking Paroxetine went into remission.

Participants also suffered more side-effects by taking Paroxetine with 269 adverse effects being reported over the treatment period. Those taking St John's Wort reported 172 adverse effects – the most common in both cases being stomach disorders.

The authors support the use of St John's Wort as an alternative to treat depression and welcome more research in this area.
 

- Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s Wort): randomised controlled double blind non-inferiority trial versus paroxetine BMJ Online First
 

BMJ-British Medical Journal

 
Subscribe to Antidepressants Newsletter
E-mail Address:

 

* Clinical name hypericum extract WS 5570
** Paroxetine is a Selective Serotonin Reuptake Inhibitor (SSRI) drug – a class of anti-depressants


Related Antidepressants News

STAR*D Trial: Third antidepressant medication might help in treatment-resistant depression
SSRI anti-depressants may cause stillbirth
Anti-depressant use associated with increased risk for heart patients
SSRIs linked with increased risk of persistent pulmonary hypertension in newborns
Antidepressants may affect human immune system
Suicide risk decrease after initiation of antidepressants
'Promiscuous' area of brain could explain role of antidepressants
Cordance QEEG can assess Susceptibility to Antidepressant Side Effects
Research shows St. John's Wart as effective as Paroxetine
Multiple Medication Use Increase as a Function of Age and Antidepressant Use,studies show


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us